Coeptis Therapeutics logo

Coeptis Therapeutics Share Price (NASDAQ: COEP)

$13.44

0.78

(6.16%)

Last updated on

Check the interactive Coeptis Therapeutics Stock chart to analyse performance

Coeptis Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$12.70
    Today's High:$13.45

    Day's Volatility :5.58%

  • 52 Weeks Low:$2.31
    52 Weeks High:$14.70

    52 Weeks Volatility :84.29%

Coeptis Therapeutics Stock Returns

PeriodCoeptis Therapeutics Holdings IncIndex (Russel 2000)
3 Months
44.19%
0.0%
6 Months
26.99%
0.0%
1 Year
237.27%
0.0%
3 Years
-65.62%
-4.7%

Coeptis Therapeutics Holdings Inc Key Stats

Check Coeptis Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$12.66
Open
$12.7
Today's High
$13.45
Today's Low
$12.7
Market Capitalization
$61.0M
Today's Volume
$41.6K
52 Week High
$14.7
52 Week Low
$2.31
Revenue TTM
$263.6K
EBITDA
$-11.8M
Earnings Per Share (EPS)
$-6.87
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-372.12%

Stock Returns calculator for Coeptis Therapeutics Stock including INR - Dollar returns

The Coeptis Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Coeptis Therapeutics investment value today

Current value as on today

₹3,42,973

Returns

₹2,42,973

(+242.97%)

Returns from Coeptis Therapeutics Stock

₹2,37,688 (+237.69%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Coeptis Therapeutics Stock

-100%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Coeptis Therapeutics Stock from India on INDmoney has decreased by -100% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Coeptis Therapeutics Holdings Inc

  • Name

    Holdings %

  • Vanguard Group Inc

    0.66%

  • Geode Capital Management, LLC

    0.48%

  • UBS Group AG

    0.21%

  • Steward Partners Investment Advisory, LLC

    0.02%

  • Advisor Group Holdings, Inc.

    0.01%

  • Tower Research Capital LLC

    0.01%

Analyst Recommendation on Coeptis Therapeutics Stock

Rating
Trend

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Coeptis Therapeutics(by analysts ranked 0 to 5 stars)

Coeptis Therapeutics Share Price Target

What analysts predicted

Downside of 77.68%

Target:

$3.00

Current:

$13.44

Coeptis Therapeutics share price target is $3.00, a slight Downside of 77.68% compared to current price of $13.44 as per analysts' prediction.

Coeptis Therapeutics Stock Insights

  • Price Movement

    In the last 1 month, COEP stock has moved up by 22.8%
  • COEP vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 177.7%

Coeptis Therapeutics Technicals Summary

Sell

Neutral

Buy

Coeptis Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Coeptis Therapeutics Holdings Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Coeptis Therapeutics Holdings Inc logo
26.51%
26.99%
237.27%
-65.62%
-83.44%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its product portfolio and rights are licensed from Deverra Therapeutics, including an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, natural killer cell therapy technology. Its product pipeline consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy; and SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological and solid tumors. In addition, the company offers its drugs for acute myeloid leukemia and acute respiratory diseases. Coeptis Therapeutics Holdings, Inc. has co-development agreement Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. The company was founded in 2017 and is headquartered in Wexford, Pennsylvania.
Organization
Coeptis Therapeutics
Employees
5
CEO
Mr. David Mehalick
Industry
Miscellaneous

Key Management of Coeptis Therapeutics Holdings Inc

NameTitle
Mr. David Mehalick
Co-Founder, Chairman of the Board, CEO & President
Ms. Christine Elise Sheehy
Co-Founder and VP of Compliance & Corporate Secretary
Mr. Daniel Alexander Yerace
Co-Founder, VP of Operations & Director
Mr. Brian Cogley M.B.A.
Chief Financial Officer
Dr. Colleen Delaney M.D., M.Sc.
Consultant

Important FAQs about investing in COEP Stock from India :

What is Coeptis Therapeutics share price today?

Coeptis Therapeutics share price today is $13.44 as on at the close of the market. Coeptis Therapeutics share today touched a day high of $13.45 and a low of $12.70.

What is the 52 week high and 52 week low for Coeptis Therapeutics share?

Coeptis Therapeutics share touched a 52 week high of $14.70 and a 52 week low of $2.31. Coeptis Therapeutics stock price today i.e. is closed at $13.44, lower by 8.57% versus the 52 week high.

How to invest in Coeptis Therapeutics Stock (COEP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Coeptis Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Coeptis Therapeutics Shares that will get you 0.1116 shares as per Coeptis Therapeutics share price of $13.44 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Coeptis Therapeutics Stock (COEP) from India?

Indian investors can start investing in Coeptis Therapeutics (COEP) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Coeptis Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Coeptis Therapeutics share’s latest price of $13.44 as on August 30, 2025 at 1:29 am IST, you will get 0.7440 shares of Coeptis Therapeutics. Learn more about fractional shares .

What are the returns that Coeptis Therapeutics has given to Indian investors in the last 5 years?

Coeptis Therapeutics stock has given -83.44% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?